756 related articles for article (PubMed ID: 35706473)
1. Pre-Exposure Prophylaxis Barriers, Facilitators and Unmet Need Among Rural People Who Inject Drugs: A Qualitative Examination of Syringe Service Program Client Perspectives.
Surratt HL; Yeager HJ; Adu A; González EA; Nelson EO; Walker T
Front Psychiatry; 2022; 13():905314. PubMed ID: 35706473
[TBL] [Abstract][Full Text] [Related]
2. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.
Biello KB; Bazzi AR; Mimiaga MJ; Biancarelli DL; Edeza A; Salhaney P; Childs E; Drainoni ML
Harm Reduct J; 2018 Nov; 15(1):55. PubMed ID: 30419926
[TBL] [Abstract][Full Text] [Related]
3. Factors that influence enrollment in syringe services programs in rural areas: a qualitative study among program clients in Appalachian Kentucky.
Ibragimov U; Cooper KE; Batty E; Ballard AM; Fadanelli M; Gross SB; Klein EM; Lockard S; Young AM; Cooper HLF
Harm Reduct J; 2021 Jun; 18(1):68. PubMed ID: 34193165
[TBL] [Abstract][Full Text] [Related]
4. "Take services to the people": strategies to optimize uptake of PrEP and harm reduction services among people who inject drugs in Uganda.
Kamusiime B; Beima-Sofie K; Chhun N; Nalumansi A; Nalukwago GK; Kasiita V; Twesige CC; Kansiime R; Muwonge TR; Kyambadde P; Kadama H; Mudiope P; Glick S; Lambdin B; Mujugira A; Heffron R
Addict Sci Clin Pract; 2024 Feb; 19(1):13. PubMed ID: 38395940
[TBL] [Abstract][Full Text] [Related]
5. Qualitative inquiry into perceptions of HIV pre-exposure prophylaxis among people who inject drugs living with hepatitis C in Seattle, WA, USA.
Barry MP; Austin EJ; Bhatraju EP; Glick SN; Stekler JD; Tung EL; Hansen RN; Williams EC; Gojic AJ; Pickering EI; Tsui JI
Harm Reduct J; 2022 Nov; 19(1):121. PubMed ID: 36320005
[TBL] [Abstract][Full Text] [Related]
6. A qualitative study of service engagement and unmet needs among unstably housed people who inject drugs in Massachusetts.
Hassan R; Roland KB; Hernandez B; Goldman L; Evans KN; Gaul Z; Agnew-Brune C; Buchacz K; Fukuda HD
J Subst Abuse Treat; 2022 Jul; 138():108722. PubMed ID: 35067399
[TBL] [Abstract][Full Text] [Related]
7. Study protocol for an efficacy trial of the "PrEP for Health" intervention to increase HIV PrEP use among people who inject drugs.
Bazzi AR; Bordeu M; Baumgartner K; Sproesser DM; Bositis CM; Krakower DS; Mimiaga MJ; Biello KB
BMC Public Health; 2023 Mar; 23(1):513. PubMed ID: 36932369
[TBL] [Abstract][Full Text] [Related]
8. Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services.
Bartholomew TS; Plesons M; Serota DP; Alonso E; Metsch LR; Feaster DJ; Ucha J; Suarez E; Forrest DW; Chueng TA; Ciraldo K; Brooks J; Smith JD; Barocas JA; Tookes HE
Addict Sci Clin Pract; 2024 Mar; 19(1):21. PubMed ID: 38528570
[TBL] [Abstract][Full Text] [Related]
9. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
[TBL] [Abstract][Full Text] [Related]
10. Motivation to Change and Treatment Participation Among Syringe Service Program Utilizers in Rural Kentucky.
Surratt HL; Otachi JK; Williams T; Gulley J; Lockard AS; Rains R
J Rural Health; 2020 Mar; 36(2):224-233. PubMed ID: 31415716
[TBL] [Abstract][Full Text] [Related]
11. Using nominal group technique to identify barriers and facilitators to preventing HIV using combination same-day pre-exposure prophylaxis and medications for opioid use disorder.
Eger WH; Altice FL; Lee J; Vlahov D; Khati A; Osborne S; Wickersham JA; Bohonnon T; Powell L; Shrestha R
Harm Reduct J; 2022 Oct; 19(1):120. PubMed ID: 36307817
[TBL] [Abstract][Full Text] [Related]
12. Exploring the impact of the COVID-19 pandemic on syringe services programs in rural Kentucky.
Glick JL; Grieb SM; Harris SJ; Weir BW; Smith KC; Puryear T; Hamilton White R; Allen ST
Harm Reduct J; 2022 May; 19(1):47. PubMed ID: 35590373
[TBL] [Abstract][Full Text] [Related]
13. Law enforcement and syringe services program implementation in rural counties in Kentucky: a qualitative exploration.
Allen ST; Danforth S; Grieb SM; Glick JL; Harris SJ; Tomko C; Sherman SG
Harm Reduct J; 2022 Sep; 19(1):109. PubMed ID: 36180853
[TBL] [Abstract][Full Text] [Related]
14. Barriers and Facilitators to PrEP Use Among People Who Inject Drugs in Rural Appalachia: A Qualitative Study.
Allen ST; O'Rourke A; White RH; Smith KC; Weir B; Lucas GM; Sherman SG; Grieb SM
AIDS Behav; 2020 Jun; 24(6):1942-1950. PubMed ID: 31853771
[TBL] [Abstract][Full Text] [Related]
15. Patient and Provider Perspectives on a Novel, Low-Threshold HIV PrEP Program for People Who Inject Drugs Experiencing Homelessness.
Bazzi AR; Shaw LC; Biello KB; Vahey S; Brody JK
J Gen Intern Med; 2023 Mar; 38(4):913-921. PubMed ID: 35614171
[TBL] [Abstract][Full Text] [Related]
16. Providing medication for opioid use disorder and HIV pre-exposure prophylaxis at syringe services programs via telemedicine: a pilot study.
McKellar MS; Des Marais AC; Chen H; Choi Y; Lilly R; Ayers D; Bennett J; Kestner L; Perry B; Poley S; Corneli A; Meade CS; Sachdeva N
Harm Reduct J; 2024 Mar; 21(1):69. PubMed ID: 38532395
[TBL] [Abstract][Full Text] [Related]
17. PrEP Care Continuum Engagement Among Persons Who Inject Drugs: Rural and Urban Differences in Stigma and Social Infrastructure.
Walters SM; Frank D; Van Ham B; Jaiswal J; Muncan B; Earnshaw V; Schneider J; Friedman SR; Ompad DC
AIDS Behav; 2022 Apr; 26(4):1308-1320. PubMed ID: 34626265
[TBL] [Abstract][Full Text] [Related]
18. Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation.
Corneli A; Perry B; Des Marais A; Choi Y; Chen H; Lilly R; Ayers D; Bennett J; Kestner L; Meade CS; Sachdeva N; McKellar MS
Harm Reduct J; 2022 Dec; 19(1):132. PubMed ID: 36463214
[TBL] [Abstract][Full Text] [Related]
19. M
Martel-Laferrière V; Feaster DJ; Metsch LR; Schackman BR; Loignon C; Nosyk B; Tookes H; Behrends CN; Arruda N; Adigun O; Goyer ME; Kolber MA; Mary JF; Rodriguez AE; Yanez IG; Pan Y; Khemiri R; Gooden L; Sako A; Bruneau J
Trials; 2022 Apr; 23(1):341. PubMed ID: 35461260
[TBL] [Abstract][Full Text] [Related]
20. Perspectives on pre-exposure prophylaxis for people who inject drugs in the context of an hiv outbreak: A qualitative study.
Smith M; Elliott L; Hutchinson SJ; Metcalfe R; Flowers P; McAuley A
Int J Drug Policy; 2021 Feb; 88():103033. PubMed ID: 33249313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
